BIOLIFE SOLUTIONS INC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Biolife Solutions Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Biolife Solutions Inc Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 46.2M shares, a 5.47% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 46.2M +2.4M +5.47% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 46.1M +2.66M +6.13% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 45.7M +2.4M +5.54% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 45.2M +2.33M +5.45% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 43.8M +1.13M +2.64% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 43.4M +906K +2.13% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 43.3M +959K +2.27% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 42.8M +1.01M +2.43% Dec 31, 2022 10-K 2024-02-29
Q3 2022 42.7M +1.26M +3.05% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 42.5M +1.98M +4.87% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 42.3M +8.7M +25.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 41.8M +8.78M +26.6% Dec 31, 2021 10-K 2023-03-31
Q3 2021 41.4M +9.31M +29% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 40.6M +14.6M +56.1% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 33.6M +12.5M +59% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 33M +12.2M +58.6% Dec 31, 2020 10-K 2022-03-31
Q3 2020 32.1M +11.8M +57.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 26M +7.08M +37.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 21.1M +2.43M +13% Mar 31, 2020 10-Q 2020-05-29
Q4 2019 20.8M +2.28M +12.3% Dec 31, 2019 10-K 2021-03-31
Q3 2019 20.3M +2.11M +11.6% Sep 30, 2019 10-K 2020-05-15
Q2 2019 18.9M +2.79M +17.3% Jun 30, 2019 10-K 2020-05-15
Q1 2019 18.7M +4.57M +32.3% Mar 31, 2019 10-K 2020-05-15
Q4 2018 18.5M +4.53M +32.3% Dec 31, 2018 10-K 2020-05-15
Q3 2018 18.2M +4.9M +36.8% Sep 30, 2018 10-K 2020-05-15
Q2 2018 16.1M +2.9M +21.9% Jun 30, 2018 10-K 2020-05-15
Q1 2018 14.1M +1.13M +8.67% Mar 31, 2018 10-K 2020-05-15
Q4 2017 14M +1.16M +9% Dec 31, 2017 10-K 2019-03-15
Q3 2017 13.3M +565K +4.42% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 13.2M +603K +4.78% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 13M +508K +4.06% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 12.9M +415K +3.34% Dec 31, 2016 10-K 2018-03-09
Q3 2016 12.8M +596K +4.9% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 12.6M +452K +3.72% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 12.5M +401K +3.31% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 12.4M +364K +3.01% Dec 31, 2015 10-K 2017-03-15
Q3 2015 12.2M +119K +0.99% Sep 30, 2015 10-Q/A 2015-11-16
Q2 2015 12.2M +128K +1.06% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 12.1M +165K +1.39% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 12.1M +7.05M +140% Dec 31, 2014 10-K 2016-02-25
Q3 2014 12.1M -58.4M -82.9% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 12M -58M -82.8% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 11.9M -58.1M -82.9% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 5.03M +53.9K +1.08% Dec 31, 2013 10-K 2015-03-12
Q3 2013 70.4M +735K +1.06% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 70M +356K +0.51% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 70M +356K +0.51% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 4.98M -64.7M -92.9% Dec 31, 2012 10-K 2014-02-12
Q3 2012 69.7M 0 0% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 69.7M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 69.7M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 69.7M 0 0% Dec 31, 2011 10-K 2013-03-29
Q3 2011 69.7M Sep 30, 2011 10-Q 2011-11-14
Q4 2010 69.7M Dec 31, 2010 10-K 2012-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.